Lung cancer patients with high serum IL-17 expression have a significantly higher risk of brain metastasis, and the IL-17 level in cerebrospinal fluid was significantly higher in lung cancer patients with brain metastasis than in those without brain metastasis; this suggests that IL-17 may play an important role in the metastasis of lung cancer to the brain [39]. This evidence concerns the gene IL17A and lung carcinoma.